HomeNewsBusinessGovt to spend Rs 25,000 crore in next five years to develop new and existing airports

Govt to spend Rs 25,000 crore in next five years to develop new and existing airports

The Airports Authority of India to spend Rs 25,000 crore in the next five years to boost infrastructure facilities.

March 14, 2022 / 18:45 IST
Story continues below Advertisement
The new arrival terminal at Delhi airport. (Source: GMR)
The new arrival terminal at Delhi airport. (Source: GMR)

In a bid to meet the increasing demand in the aviation sector, the central government will spend Rs 25,000 crore in the next five years to develop new and existing airports across the country, Minister of State in the Ministry of Civil Aviation, VK Singh said in a written reply to a question in the Rajya Sabha on March 14.

As part of the plan, the Airports Authority of India (AAI) will spend Rs 25,000 crore in the next five years to construct new terminals, expand and modify existing terminals, expand or strengthen existing runways, aprons, Airport Navigation Services (ANS) infrastructure, control towers and technical blocks.

Story continues below Advertisement

The government is also looking to invest Rs 36,000 under public-private partnerships for the development of new greenfield airports across the country. So far 'in-principle' approval has been given to set up 21 greenfield airports across the country.

Out of the aforementioned 21, eight airports at Sindhudurg and Shirdi in Maharashtra, Durgapur in West Bengal, Pakyong in Sikkim, Kannur in Kerala, Orvakal in Andhra Pradesh, Kalaburagi in Karnataka and Kushinagar in Uttar Pradesh have been operationalised, the government said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show